Semaglutide: A Promising Ally Against Alzheimer’s?

In a groundbreaking study, researchers at Case Western Reserve School of Medicine have identified a potential new benefit of semaglutide, a widely used diabetes and weight-loss drug. According to their findings, semaglutide may significantly reduce the risk of Alzheimer’s disease in individuals with type 2 diabetes (T2D), outperforming seven other anti-diabetic medications.

Alzheimer’s disease, a devastating brain disorder that erodes memory and cognitive abilities, affects nearly 7 million Americans aged 65 and older, as reported by the Alzheimer’s Association. Alarmingly, it claims more lives annually than breast and prostate cancer combined.

Published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, the study suggests that T2D patients taking semaglutide had a markedly lower risk of developing Alzheimer’s disease. This trend was consistent across various subgroups, regardless of obesity status, gender, or age.

Semaglutide, a glucagon-like peptide receptor (GLP-1R) agonist, is the active ingredient in popular medications like Wegovy and Ozempic. It works by reducing hunger and regulating blood sugar levels in T2D patients.

Rong xu

Under the leadership of Rong Xu, a professor of biomedical informatics, the research team analyzed three years of electronic health records from nearly one million U.S. patients with T2D. Their statistical approach, which mimicked a randomized clinical trial, revealed that patients prescribed semaglutide had a significantly lower risk of Alzheimer’s compared to those on other anti-diabetic medications.

According to the CDC, Alzheimer’s disease results in approximately 120,000 deaths annually, ranking as the seventh-leading cause of death in the United States.

“This new study provides real-world evidence for semaglutide’s potential impact on Alzheimer’s disease,” Xu stated. “While preclinical research has hinted at its protective effects against neurodegeneration and neuroinflammation, our findings suggest the need for further exploration through randomized clinical trials.”

Despite these promising results, the study’s limitations prevent researchers from drawing definitive causal conclusions. Xu emphasized the importance of continued research into semaglutide’s potential as a treatment for this debilitating condition, encouraging further investigation into alternative drugs.

For more information, please contact Patty Zamora at [email protected].

More Articles

Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!

Fed Survey Shows Only Two More Rate Cuts Expected, Even if Trump Appoints a New Fed Chair

A new CNBC Fed Survey reveals that economists expect just two additional interest rate cuts in 2026 and none in 2027, even if President Donald Trump appoints a more dovish Federal Reserve chair. Strong economic growth, stable inflation, and reduced recession fears are keeping rate‑cut expectations limited, signaling a more stable long‑term environment for real estate, mortgage, and financial professionals.

15 States on the Brink: America’s Insurance Crisis Is Spreading Faster Than Anyone Expected

A nationwide insurance crisis is accelerating as climate‑driven disasters push premiums higher, force insurers out of multiple states, and reshape real estate and mortgage markets. Once limited to Florida and California, the instability now threatens 15 states where losses, extreme weather, and insurer withdrawals are creating mounting risks for homeowners and industry professionals alike.

Commercial Real Estate in 2026: Rightsizing, Cool Offices, and a Market Waiting for Clarity

Commercial real estate is entering 2026 with a cautious but strategic shift. Companies are ditching oversized offices in favor of smaller, higher‑quality spaces packed with amenities that attract today’s workforce. Downtown markets like Portland remain steady, while suburban vacancies rise and landlords get creative with incentives. Industrial real estate is cooling after years of explosive growth, and developers are hesitating—though multifamily and hotel projects continue to push forward. Overall, the theme of the year is patience, as businesses wait for clearer signals on interest rates, construction costs, and long‑term workplace trends.

The Real Reason Housing Isn’t Affordable—And Why Deregulation Won’t Save Us

A new study from leading urban scholars reveals that zoning laws and construction slowdowns aren’t the true cause of America’s housing crisis. Even with massive building booms, rents would barely drop for decades. The real culprit? Soaring economic inequality. Until the widening wealth gap is addressed, policies like upzoning and deregulation won’t make housing affordable for working Americans—and may even push prices higher.

Cambio Raises $18M To Transform Commercial Real Estate Workflows With AI

Cambio, a fast‑growing AI proptech company, has secured an $18 million Series A at a $100 million valuation, aiming to overhaul how commercial real estate firms process documents and make investment decisions. By converting messy PDFs, spreadsheets, and audit files into investor‑ready insights in minutes, the platform is rapidly expanding—now active in 35 countries and managing data for over 2 billion square feet of assets.

Florida’s Insurance Market Enters 2026 With Rare Good News — Stability Returns for Homeowners and Real Estate Professionals

Florida’s insurance market is finally showing signs of real recovery heading into 2026. Industry leaders say recent legal reforms have sharply reduced lawsuits, allowing insurers to stabilize rates — and even introduce reductions for the first time in years. With new companies entering the state and solvency at its strongest level in more than a decade, real estate and mortgage professionals may benefit from improved buyer confidence and smoother closings as insurance becomes more predictable again.